Literature DB >> 3027980

Partial nucleotide sequence of St. Louis encephalitis virus RNA: structural proteins, NS1, ns2a, and ns2b.

D W Trent, R M Kinney, B J Johnson, A V Vorndam, J A Grant, V Deubel, C M Rice, C Hahn.   

Abstract

cDNA clones of the St. Louis encephalitis (SLE) virus genome have been obtained and the nucleotide sequence of 4.7 kb corresponding to the 5' terminal half of the genome determined. The genome contains a 5' noncoding region of 98 nucleotides followed by a single continuous open reading frame that encodes three structural proteins in the order capsid (C), membrane precursor (prM)-membrane (M), and envelope (E). Immediately following the C-terminus of E are located nonstructural proteins NS1 through NS3. The SLE amino acid sequence homology with yellow fever (YF), Murray Valley encephalitis (MVE), West Nile (WN), and dengue-2 (DEN) viruses over the sequenced region is 39, 66, 64, and 43%, respectively. The start of each SLE protein has been assigned on the basis of N-terminal sequence data and potential proteolytic cleavage sites homologous with YF and MVE viruses. Flaviviruses have conserved glycosylation sites in prM and NS1 proteins, although only one of the two glycosylation sites in the SLE E protein is conserved in MVE and DEN viruses. An evolutionary tree showing relationships of SLE, MVE, WN, YF, and DEN-2 flaviviruses is proposed on the basis of the amino acid sequences of the C proteins.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3027980     DOI: 10.1016/0042-6822(87)90409-0

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  19 in total

1.  Proper processing of dengue virus nonstructural glycoprotein NS1 requires the N-terminal hydrophobic signal sequence and the downstream nonstructural protein NS2a.

Authors:  B Falgout; R Chanock; C J Lai
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

2.  Flavivirus enzyme-substrate interactions studied with chimeric proteinases: identification of an intragenic locus important for substrate recognition.

Authors:  F Preugschat; E M Lenches; J H Strauss
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

3.  Cleavage of dengue virus NS1-NS2A requires an octapeptide sequence at the C terminus of NS1.

Authors:  H Hori; C J Lai
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

4.  In vitro processing of dengue virus structural proteins: cleavage of the pre-membrane protein.

Authors:  L Markoff
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

5.  Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model.

Authors:  C W Mandl; F Guirakhoo; H Holzmann; F X Heinz; C Kunz
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

6.  A single amino acid substitution in envelope protein E of tick-borne encephalitis virus leads to attenuation in the mouse model.

Authors:  H Holzmann; F X Heinz; C W Mandl; F Guirakhoo; C Kunz
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

Review 7.  The dengue viruses.

Authors:  E A Henchal; J R Putnak
Journal:  Clin Microbiol Rev       Date:  1990-10       Impact factor: 26.132

8.  NS2B-3 proteinase-mediated processing in the yellow fever virus structural region: in vitro and in vivo studies.

Authors:  S M Amberg; A Nestorowicz; D W McCourt; C M Rice
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

9.  A rapid method for detection and identification of flaviviruses by polymerase chain reaction and nucleic acid hybridization.

Authors:  B Puri; E A Henchal; J Burans; K R Porter; W Nelson; D M Watts; C G Hayes
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

10.  Noninfectious recombinant antigen for detection of St. Louis encephalitis virus-specific antibodies in serum by enzyme-linked immunosorbent assay.

Authors:  David E Purdy; Amanda J Noga; Gwong-Jen J Chang
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.